




Searching News Database: acne
HSMN NewsFeed - 15 Oct 2024
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
HSMN NewsFeed - 23 Dec 2022
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
HSMN NewsFeed - 22 Nov 2022
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
HSMN NewsFeed - 6 Oct 2022
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
HSMN NewsFeed - 25 Jan 2021
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
HSMN NewsFeed - 8 Sep 2020
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
HSMN NewsFeed - 23 Jun 2020
Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States
Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States
HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
HSMN NewsFeed - 11 Jun 2020
Sciton Unveils Newest Aesthetic Platform, mJOULE(TM) Featuring BBL HERO(TM) And MOXI(TM)
Sciton Unveils Newest Aesthetic Platform, mJOULE(TM) Featuring BBL HERO(TM) And MOXI(TM)
HSMN NewsFeed - 18 May 2020
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
HSMN NewsFeed - 16 Mar 2020
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
HSMN NewsFeed - 21 Nov 2019
Silk Medical Aesthetics Completes Enrollment in Clinical Trial for Industry's First Silk-Based Dermal Filler
Silk Medical Aesthetics Completes Enrollment in Clinical Trial for Industry's First Silk-Based Dermal Filler
HSMN NewsFeed - 28 Mar 2019
Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
HSMN NewsFeed - 28 Mar 2019
Sciton Unveils New JOULE X Platfor(TM)m During ASLMS, Bringing Realtime Aesthetic Insights Into Your Hands
Sciton Unveils New JOULE X Platfor(TM)m During ASLMS, Bringing Realtime Aesthetic Insights Into Your Hands
HSMN NewsFeed - 5 Feb 2019
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
HSMN NewsFeed - 21 Nov 2018
FDA Closes Inquiry Regarding IHCTOA Letter Regarding Sciton's diVa(R) Laser
FDA Closes Inquiry Regarding IHCTOA Letter Regarding Sciton's diVa(R) Laser
HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
HSMN NewsFeed - 17 Sep 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
HSMN NewsFeed - 24 Aug 2018
Ortho Dermatologics Receives FDA Approval For ALTRENO(TM) (tretinoin 0.05%) Lotion For Acne
Ortho Dermatologics Receives FDA Approval For ALTRENO(TM) (tretinoin 0.05%) Lotion For Acne
HSMN NewsFeed - 19 Jul 2018
BioPharmX Announces FDA Grant of CARC Waiver and Post-Hoc Analysis for BPX-01
BioPharmX Announces FDA Grant of CARC Waiver and Post-Hoc Analysis for BPX-01
HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
HSMN NewsFeed - 4 Jun 2018
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
HSMN NewsFeed - 26 Oct 2017
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
HSMN NewsFeed - 29 Sep 2017
Dermavant Sciences Appoints Vince Ippolito as President and Chief Operating Officer
Dermavant Sciences Appoints Vince Ippolito as President and Chief Operating Officer
HSMN NewsFeed - 24 May 2017
Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
HSMN NewsFeed - 15 May 2017
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
HSMN NewsFeed - 1 Feb 2017
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
HSMN NewsFeed - 29 Nov 2016
Cynosure Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China
Cynosure Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China
HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
HSMN NewsFeed - 14 Jun 2016
Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities
Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities
HSMN NewsFeed - 2 May 2016
Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel
Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel
HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 11 Jan 2016
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
HSMN NewsFeed - 7 Oct 2015
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
HSMN NewsFeed - 24 Apr 2015
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
HSMN NewsFeed - 25 Nov 2014
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris
HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
HSMN NewsFeed - 19 Aug 2014
Aqua Pharmaceuticals, LLC Welcomes Nathan Mitchell as Senior Director, Marketing
Aqua Pharmaceuticals, LLC Welcomes Nathan Mitchell as Senior Director, Marketing
HSMN NewsFeed - 4 Aug 2014
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 14 Apr 2014
Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction
Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction
HSMN NewsFeed - 31 Jan 2014
Valeant Pharmaceuticals Announces Approval of Retin-A Micro(R) Microsphere 0.08%
Valeant Pharmaceuticals Announces Approval of Retin-A Micro(R) Microsphere 0.08%
HSMN NewsFeed - 30 Dec 2013
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
HSMN NewsFeed - 2 Oct 2013
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
HSMN NewsFeed - 19 Sep 2013
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
HSMN NewsFeed - 20 Jun 2013
Fraxel(R) Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation
Fraxel(R) Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation
HSMN NewsFeed - 14 May 2013
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
HSMN NewsFeed - 18 Mar 2013
Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies
Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies
HSMN NewsFeed - 26 Feb 2013
Brickell Biotech Announces $7M Series B Financing to Fund Development of Novel Dermatology Treatments
Brickell Biotech Announces $7M Series B Financing to Fund Development of Novel Dermatology Treatments
HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
HSMN NewsFeed - 11 Oct 2012
Alma Lasers Receives FDA Clearance for PixelRF Breakthrough Technology in Skin Resurfacing
Alma Lasers Receives FDA Clearance for PixelRF Breakthrough Technology in Skin Resurfacing
HSMN NewsFeed - 4 Jun 2012
FDA Clears Erchonia’s Zerona Laser for the Non-Invasive Reduction of the Arms
FDA Clears Erchonia’s Zerona Laser for the Non-Invasive Reduction of the Arms
HSMN NewsFeed - 3 May 2012
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
HSMN NewsFeed - 13 Apr 2012
Chromogenex Receives FDA Clearance for Circumferential Reduction for i-Lipo Body Contouring System
Chromogenex Receives FDA Clearance for Circumferential Reduction for i-Lipo Body Contouring System
HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
HSMN NewsFeed - 10 Jun 2011
Avita Medical Reports Additional Market Acceptance of its ReCell(R) Spray-On-Skin(TM)
Avita Medical Reports Additional Market Acceptance of its ReCell(R) Spray-On-Skin(TM)
HSMN NewsFeed - 6 May 2011
Solta Medical Announces FDA 510(k) Clearance for New Clear + Brilliant Technology
Solta Medical Announces FDA 510(k) Clearance for New Clear + Brilliant Technology
HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
HSMN NewsFeed - 14 Dec 2010
Smiths Medical Introduces Wireless Version of the Medfusion(R) Syringe Infusion System
Smiths Medical Introduces Wireless Version of the Medfusion(R) Syringe Infusion System
HSMN NewsFeed - 28 Jun 2010
Solta Medical Announces Thermage CPT and Fraxel re:store(R) Dual Systems Receive Health Canada Approval
Solta Medical Announces Thermage CPT and Fraxel re:store(R) Dual Systems Receive Health Canada Approval
HSMN NewsFeed - 7 May 2010
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
HSMN NewsFeed - 22 Feb 2010
Syneron Receives FDA Clearance for Expanded Indications of eMatrix(TM) Sublative Rejuvenation System
Syneron Receives FDA Clearance for Expanded Indications of eMatrix(TM) Sublative Rejuvenation System
HSMN NewsFeed - 5 Jan 2010
Syneron Medical Ltd. Successfully Completes Merger With Candela Corporation
Syneron Medical Ltd. Successfully Completes Merger With Candela Corporation
HSMN NewsFeed - 16 Dec 2009
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
HSMN NewsFeed - 18 Nov 2009
Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
HSMN NewsFeed - 5 Nov 2009
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 28 Oct 2009
Safeguard Scientifics Leads $17.4 Million Series B Financing for Quinnova Pharmaceuticals
Safeguard Scientifics Leads $17.4 Million Series B Financing for Quinnova Pharmaceuticals
HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 21 Sep 2009
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 9 Sep 2009
Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company
Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company
HSMN NewsFeed - 27 Aug 2009
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 18 Jun 2009
Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
HSMN NewsFeed - 20 Apr 2009
Syneron Medical Moves Forward in Shift Toward Recurring Revenue Models in Response to New Market Environment
Syneron Medical Moves Forward in Shift Toward Recurring Revenue Models in Response to New Market Environment
HSMN NewsFeed - 20 Apr 2009
GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
HSMN NewsFeed - 2 Apr 2009
Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
HSMN NewsFeed - 24 Mar 2009
Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 6 Mar 2009
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
HSMN NewsFeed - 5 Mar 2009
Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
HSMN NewsFeed - 17 Feb 2009
Cipher receives tentative FDA approval for extended-release tramadol capsules
Cipher receives tentative FDA approval for extended-release tramadol capsules
HSMN NewsFeed - 19 Nov 2008
FDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter Home Use
FDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter Home Use
HSMN NewsFeed - 18 Nov 2008
Palomar's Hair Removal Lawsuit Against Candela Stayed Pending Re-Examination By United States Patent Office
Palomar's Hair Removal Lawsuit Against Candela Stayed Pending Re-Examination By United States Patent Office
HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
HSMN NewsFeed - 17 Sep 2008
Valeant Pharmaceuticals Signs Agreement to Acquire Coria Laboratories, Ltd.
Valeant Pharmaceuticals Signs Agreement to Acquire Coria Laboratories, Ltd.
HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 12 Sep 2008
PhotoMedex Now Distributing Omnilux Photodynamic Therapy Line by Photo Therapeutics
PhotoMedex Now Distributing Omnilux Photodynamic Therapy Line by Photo Therapeutics
HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
HSMN NewsFeed - 28 Jul 2008
Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis
Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis
HSMN NewsFeed - 23 Jul 2008
Palomar Medical Expands Its Product Portfolio Through a Distribution Agreement with Astron Clinica
Palomar Medical Expands Its Product Portfolio Through a Distribution Agreement with Astron Clinica
HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
HSMN NewsFeed - 8 Jul 2008
Stiefel Laboratories, Inc. Commences Tender Offer to Acquire Barrier Therapeutics, Inc.
Stiefel Laboratories, Inc. Commences Tender Offer to Acquire Barrier Therapeutics, Inc.
HSMN NewsFeed - 23 Jun 2008
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
HSMN NewsFeed - 29 May 2008
Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008
Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008
HSMN NewsFeed - 1 May 2008
Syneron's LipoLite(TM) Minimally Invasive Laser-Assisted Lypolysis Receives FDA Clearance
Syneron's LipoLite(TM) Minimally Invasive Laser-Assisted Lypolysis Receives FDA Clearance
HSMN NewsFeed - 21 Apr 2008
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness
HSMN NewsFeed - 14 Mar 2008
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
HSMN NewsFeed - 3 Mar 2008
Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
HSMN NewsFeed - 7 Jan 2008
CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
HSMN NewsFeed - 4 Jan 2008
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
HSMN NewsFeed - 5 Dec 2007
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 14 Nov 2007
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
HSMN NewsFeed - 29 Oct 2007
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
HSMN NewsFeed - 8 Oct 2007
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
HSMN NewsFeed - 21 Sep 2007
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
HSMN NewsFeed - 10 Sep 2007
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
Obagi Medical Products Reorganizes International Sales and Manufacturing/Distribution Business Units
HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
HSMN NewsFeed - 8 Aug 2007
Syneron's Vela(TM) Platform Receives FDA Clearance for Temporary Reduction of Thigh Circumference
Syneron's Vela(TM) Platform Receives FDA Clearance for Temporary Reduction of Thigh Circumference
HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
HSMN NewsFeed - 12 Jul 2007
Barrier Therapeutics Announces Positive Phase 2 Data With Oral Rambazole in Moderate to Severe Psoriasis
Barrier Therapeutics Announces Positive Phase 2 Data With Oral Rambazole in Moderate to Severe Psoriasis
HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
HSMN NewsFeed - 12 Jul 2007
Sciton Receives FDA Clearance for Laser-Assisted Lipolysis and Pulsed Light Wrinkle Treatment
Sciton Receives FDA Clearance for Laser-Assisted Lipolysis and Pulsed Light Wrinkle Treatment
HSMN NewsFeed - 11 Jul 2007
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
HSMN NewsFeed - 10 Jul 2007
Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen
Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen
HSMN NewsFeed - 2 Jul 2007
Reliant Technologies Receives FDA Clearance for Fraxel re:pair(TM) Laser System
Reliant Technologies Receives FDA Clearance for Fraxel re:pair(TM) Laser System
HSMN NewsFeed - 28 Jun 2007
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
HSMN NewsFeed - 14 Jun 2007
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
HSMN NewsFeed - 14 Jun 2007
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
HSMN NewsFeed - 29 May 2007
QLT USA, Inc. files Aczone(TM) labeling supplement for removal of blood screening requirement
QLT USA, Inc. files Aczone(TM) labeling supplement for removal of blood screening requirement
HSMN NewsFeed - 17 May 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
HSMN NewsFeed - 16 May 2007
Barrier Therapeutics Appoints Dr. Braham Shroot, Dermatology Expert, as New Chief Scientific Officer
Barrier Therapeutics Appoints Dr. Braham Shroot, Dermatology Expert, as New Chief Scientific Officer
HSMN NewsFeed - 14 May 2007
Syneron Announces Management Change in Support of Company's Long-Term Growth Strategies
Syneron Announces Management Change in Support of Company's Long-Term Growth Strategies
HSMN NewsFeed - 7 May 2007
Reliant Technologies Receives FDA Clearance for Fraxel re:fine(TM) Laser System
Reliant Technologies Receives FDA Clearance for Fraxel re:fine(TM) Laser System
HSMN NewsFeed - 3 May 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-TRAMADOL ER
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-TRAMADOL ER
HSMN NewsFeed - 3 May 2007
Barrier Therapeutics Receives FDA Approval for Solagé(R) Topical Solution Labeling Expansion
Barrier Therapeutics Receives FDA Approval for Solagé(R) Topical Solution Labeling Expansion
HSMN NewsFeed - 27 Apr 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-ISOTRETINOIN
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-ISOTRETINOIN
HSMN NewsFeed - 24 Apr 2007
New TNS(R) Serum From SkinMedica(R) Exclusively Applied Through HydraFacial MD(TM) by Edge Systems
New TNS(R) Serum From SkinMedica(R) Exclusively Applied Through HydraFacial MD(TM) by Edge Systems
HSMN NewsFeed - 23 Apr 2007
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology
HSMN NewsFeed - 23 Apr 2007
CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application
CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application
HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
HSMN NewsFeed - 8 Mar 2007
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
HSMN NewsFeed - 2 Feb 2007
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
HSMN NewsFeed - 1 Feb 2007
Ivrea Pharmaceuticals Appoints Daniel S. Lynch as President and Chief Executive Officer
Ivrea Pharmaceuticals Appoints Daniel S. Lynch as President and Chief Executive Officer
HSMN NewsFeed - 29 Jan 2007
Obagi Medical Products, Inc. Launches CLENZIderm M.D. Penetrating Acne Therapeutic System
Obagi Medical Products, Inc. Launches CLENZIderm M.D. Penetrating Acne Therapeutic System
HSMN NewsFeed - 10 Jan 2007
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 4 Dec 2006
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
HSMN NewsFeed - 17 Nov 2006
Fougera Receives Approval for First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
Fougera Receives Approval for First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
HSMN NewsFeed - 16 Nov 2006
The CoolTouch CTEV(TM) Endovenous Laser Now Approved to Treat Tributary Veins
The CoolTouch CTEV(TM) Endovenous Laser Now Approved to Treat Tributary Veins
HSMN NewsFeed - 9 Nov 2006
Graceway Pharmaceuticals to Acquire 3M Pharmaceuticals Business in North and Latin America
Graceway Pharmaceuticals to Acquire 3M Pharmaceuticals Business in North and Latin America
HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
HSMN NewsFeed - 23 Oct 2006
Connetics Corporation and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
Connetics Corporation and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
HSMN NewsFeed - 10 Oct 2006
Triax Pharmaceuticals Announces the Launch of MINOCIN(R) (minocycline HCl) Professional Acne Care (PAC)
Triax Pharmaceuticals Announces the Launch of MINOCIN(R) (minocycline HCl) Professional Acne Care (PAC)
HSMN NewsFeed - 5 Oct 2006
New Non-Invasive Applications for LED Light Therapy From Photo Therapeutics
New Non-Invasive Applications for LED Light Therapy From Photo Therapeutics
HSMN NewsFeed - 27 Sep 2006
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
HSMN NewsFeed - 19 Sep 2006
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
HSMN NewsFeed - 7 Sep 2006
Syneron's VelaSmooth(TM) Launches Next Wave in Cellulite Reduction With Its New Contour Applicator(TM)
Syneron's VelaSmooth(TM) Launches Next Wave in Cellulite Reduction With Its New Contour Applicator(TM)
HSMN NewsFeed - 21 Jun 2006
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
HSMN NewsFeed - 15 May 2006
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
HSMN NewsFeed - 15 May 2006
Reliant Technologies Appoints Anja Krammer as Vice President of Marketing
Reliant Technologies Appoints Anja Krammer as Vice President of Marketing
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
HSMN NewsFeed - 8 May 2006
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Additional items found! 331

Members Archive contains
331 additional stories matching:
acne
(Password required)
acne
(Password required)